Opioid Use Disorder in Pregnant and Postpartum Women: The Treatment and Policy Landscape

Opioid use disorder (OUD) can have complex, potentially fatal implications for new and expecting mothers and their babies, including low birth weight, clinical challenges with medical dosing and increased risk of accidental death. In the U.S., a baby is born passively dependent every 15 minutes. To ensure best health outcomes for both mother and child, policies must allow care providers to engage in evidence-based treatment and protect clients from legal ramifications.

Join us on May 31, 3-4 p.m. ET, for Opioid Use Disorder in Pregnant and Postpartum Women: The Treatment and Policy Landscape. We’ll hear from a physician, a clinic director and an individual with lived experience to broaden our understanding of the treatment and policy landscape for pregnant and postpartum women with OUD.

Educational Objectives:

• Review the current landscape of OUD treatment for pregnant and postpartum women in the U.S.
• Describe the neurobiology of OUD in pregnant and postpartum women.
• Examine legal challenges related to pregnant women and mothers with substance use disorders.
• Discuss recent policy changes that impact how OUD treatment is provided.

Speakers:

• Maria Manriquez, M.D., Obstetrics and Gynecology Specialist, Hushabye Nursery
• Tara Sundem, APRN, NNP-BC, Founder and Executive Director, Hushabye Nursery
• Tawni Carson, patient with lived experience